The historical rank and industry rank for Qol Holdings Co's FCF Margin % or its related term are showing as below:
TSE:3034'
s FCF Margin % Range Over the Past 10 Years
Min: -3.54 Med: 3.93 Max: 6.68
Current: 3.65
During the past 13 years, the highest FCF Margin % of Qol Holdings Co was 6.68%. The lowest was -3.54%. And the median was 3.93%.
TSE:3034's FCF Margin % is ranked better than 50.82% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.39
vs TSE:3034: 3.65
Qol Holdings Co FCF Margin % Related Terms
Qol Holdings Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Qol Holdings Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co FCF Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Qol Holdings Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qol Holdings Co FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Qol Holdings Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co (TSE:3034) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Qol Holdings Co and its competitors. According to the industry distribution chart, Qol Holdings Co ranks #329 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 49.2%.
Is Qol Holdings Co's FCF Margin % too high?
Qol Holdings Co's current FCF Margin % is 0.00%. Based on the distribution chart, Qol Holdings Co ranks #329 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Qol Holdings Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qol Holdings Co's FCF Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Qol Holdings Co ranks #329 out of 669 companies for FCF Margin %. This puts Qol Holdings Co in the upper half of its industry. The industry median FCF Margin % is 3.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Qol Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qol Holdings Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qol Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Qol Holdings Co (TSE:3034) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,274.64, compared to a current price of 円1,822.00 — trading 19.9% below its estimated fair value. The current FCF Margin % is 0.00%. Qol Holdings Co's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Qol Holdings Co (TSE:3034), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qol Holdings Co (TSE:3034) Overvalued in 2026?
Based on GuruFocus' analysis, Qol Holdings Co stock appears to be undervalued.
The current stock price of 円1,822.00 is trading 19.9% below its estimated GF Value™ of 円2,274.64.
GuruFocus considers Qol Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:3034:
FCF Margin %: 0.00%
GF Value™: 円2,274.64 vs. price of 円1,822.00 (19.9% below fair value)
No single metric tells the full story. See the TSE:3034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.
89GF Score
Get the complete analysis for TSE:3034
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3034 has been successfully added to your 
